indapamide ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
diuretics, sulfamoylbenzoic acid derivatives 1433 26807-65-8

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • metindamide
  • indapamide hemihydrate
  • indapamide
  • flupamid
  • indaflex
  • indamide
  • indamol
  • veroxil
  • (+/-)-Indapamide
A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
  • Molecular weight: 365.83
  • Formula: C16H16ClN3O3S
  • CLOGP: 2.96
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 2
  • TPSA: 92.50
  • ALOGS: -4.03
  • ROTB: 3

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
2.50 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.59 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 7 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.20 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 90 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
July 6, 1983 FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hyponatraemia 1351.44 13.68 728 24851 111172 63352271
Hypokalaemia 543.03 13.68 398 25181 103406 63360037
Acute kidney injury 234.56 13.68 397 25182 263018 63200425
Inappropriate antidiuretic hormone secretion 186.77 13.68 101 25478 15361 63448082
Drug interaction 118.15 13.68 275 25304 228856 63234587
Hypomagnesaemia 110.39 13.68 92 25487 28645 63434798
Confusional state 109.30 13.68 272 25307 236108 63227335
Hypochloraemia 109.10 13.68 38 25541 1971 63461472
Burning mouth syndrome 85.68 13.68 23 25556 488 63462955
Hyponatraemic seizure 84.10 13.68 22 25557 421 63463022
Conjoined twins 73.42 13.68 18 25561 262 63463181
Rectal polyp 73.35 13.68 25 25554 1214 63462229
Blood pressure increased 71.17 13.68 183 25396 161879 63301564
Torsade de pointes 69.14 13.68 51 25528 13300 63450143
Maternal exposure during pregnancy 66.64 13.68 6 25573 220056 63243387
Labile hypertension 63.58 13.68 18 25561 468 63462975
Pemphigus 58.45 13.68 4 25575 183722 63279721
Drug ineffective 58.33 13.68 221 25358 1044544 62418899
Change of bowel habit 56.14 13.68 24 25555 2169 63461274
Congenital bladder anomaly 54.25 13.68 13 25566 171 63463272
Intestinal malrotation 53.93 13.68 15 25564 365 63463078
Urachal abnormality 53.70 13.68 13 25566 179 63463264
Electrocardiogram QT prolonged 53.09 13.68 90 25489 59440 63404003
Persistent cloaca 52.85 13.68 13 25566 192 63463251
Intestinal haemorrhage 51.72 13.68 27 25552 3820 63459623
Off label use 50.88 13.68 124 25455 674338 62789105
Proctalgia 47.49 13.68 30 25549 6080 63457363
Atrial fibrillation 47.39 13.68 128 25451 116508 63346935
Death 46.94 13.68 49 25530 374332 63089111
Sensitisation 46.19 13.68 24 25555 3362 63460081
Left ventricular hypertrophy 46.14 13.68 28 25551 5287 63458156
Infection 45.01 13.68 18 25561 229155 63234288
Product packaging confusion 44.50 13.68 11 25568 166 63463277
Urine odour abnormal 43.82 13.68 29 25550 6360 63457083
Vessel puncture site haemorrhage 42.57 13.68 10 25569 120 63463323
Arthropathy 42.09 13.68 21 25558 234771 63228672
Dehydration 41.80 13.68 159 25420 173195 63290248
Alopecia 41.39 13.68 45 25534 337491 63125952
Infusion related reaction 41.04 13.68 24 25555 245497 63217946
Central nervous system lupus 41.03 13.68 13 25566 501 63462942
Furuncle 40.72 13.68 28 25551 6538 63456905
Exposure during pregnancy 40.39 13.68 7 25572 155540 63307903
Sprue-like enteropathy 40.14 13.68 14 25565 729 63462714
Blood sodium decreased 39.81 13.68 49 25530 24203 63439240
Injection site discomfort 39.19 13.68 24 25555 4606 63458837
Needle issue 37.33 13.68 32 25547 10344 63453099
Dysuria 36.91 13.68 56 25523 33682 63429761
Glossodynia 36.87 13.68 13 25566 178863 63284580
Contraindicated product administered 36.76 13.68 21 25558 217627 63245816
Bradycardia 36.65 13.68 87 25492 73140 63390303
Duodenal ulcer 36.54 13.68 28 25551 7728 63455715
Treatment failure 35.38 13.68 18 25561 199025 63264418
Fall 35.06 13.68 274 25305 392060 63071383
Product dose omission issue 34.97 13.68 26 25553 234287 63229156
Hypertensive angiopathy 34.95 13.68 8 25571 85 63463358
Urine abnormality 34.52 13.68 26 25553 6993 63456450
Jaundice 34.07 13.68 50 25529 29201 63434242
Orthostatic hypotension 34.01 13.68 56 25523 36104 63427339
Polyp 33.96 13.68 25 25554 6496 63456947
Nasal mucosal disorder 33.90 13.68 11 25568 458 63462985
Renin increased 33.80 13.68 9 25570 185 63463258
Metabolic acidosis 33.57 13.68 63 25516 45006 63418437
Swelling 33.42 13.68 37 25542 275341 63188102
Systemic lupus erythematosus 32.73 13.68 22 25557 208896 63254547
Hyperlactacidaemia 32.70 13.68 18 25561 2831 63460612
Frustration tolerance decreased 32.42 13.68 25 25554 6963 63456480
Croup infectious 32.24 13.68 11 25568 536 63462907
Urinary incontinence 32.04 13.68 51 25528 31963 63431480
Postoperative wound infection 31.99 13.68 30 25549 10895 63452548
Discomfort 31.48 13.68 14 25565 167360 63296083
Dyslipidaemia 31.17 13.68 25 25554 7368 63456075
Eosinophilia 31.11 13.68 42 25537 22714 63440729
Bladder disorder 30.99 13.68 27 25552 8919 63454524
Hepatic enzyme increased 30.77 13.68 22 25557 202306 63261137
Blood urea increased 30.59 13.68 45 25534 26334 63437109
Renal artery stenosis 30.33 13.68 15 25564 1894 63461549
Hypotension 29.87 13.68 200 25379 272404 63191039
Diabetes mellitus 29.78 13.68 68 25511 55742 63407701
Peripheral coldness 29.27 13.68 30 25549 12135 63451308
Mass 29.20 13.68 32 25547 13968 63449475
Renal impairment 29.13 13.68 90 25489 88265 63375178
Wound 28.65 13.68 15 25564 163248 63300195
Abdominal discomfort 28.25 13.68 54 25525 320831 63142612
Lactic acidosis 27.87 13.68 53 25526 38234 63425209
Gravitational oedema 26.89 13.68 12 25567 1202 63462241
Glomerular filtration rate decreased 26.79 13.68 30 25549 13411 63450032
Hypouricaemia 26.10 13.68 7 25572 148 63463295
Diabetic metabolic decompensation 25.88 13.68 13 25566 1697 63461746
Ischaemic stroke 25.86 13.68 34 25545 17923 63445520
Blood pressure inadequately controlled 25.73 13.68 19 25560 4959 63458484
Butterfly rash 25.44 13.68 13 25566 1760 63461683
Blood electrolytes abnormal 25.16 13.68 11 25568 1050 63462393
Angioedema 25.10 13.68 58 25521 47907 63415536
Oliguria 24.77 13.68 24 25555 9077 63454366
Convulsive threshold lowered 24.40 13.68 8 25571 344 63463099
Mucocutaneous haemorrhage 24.12 13.68 6 25573 93 63463350
Sinusitis 23.79 13.68 34 25545 226619 63236824
Impaired healing 23.76 13.68 6 25573 102536 63360907
Glomerular filtration rate increased 23.56 13.68 10 25569 888 63462555
Presyncope 23.44 13.68 41 25538 27744 63435699
Circulatory collapse 23.41 13.68 36 25543 21902 63441541
Platelet dysfunction 23.33 13.68 6 25573 107 63463336
Failure to suspend medication 22.90 13.68 5 25574 42 63463401
Paramnesia 22.88 13.68 4 25575 8 63463435
Psychomotor retardation 22.82 13.68 16 25563 3854 63459589
Heart rate decreased 22.65 13.68 54 25525 45506 63417937
Thyroid disorder 22.29 13.68 29 25550 15133 63448310
Lupus nephritis 22.21 13.68 14 25565 2825 63460618
Migraine 22.18 13.68 7 25572 103339 63360104
Malaise 21.94 13.68 260 25319 415694 63047749
Rhabdomyolysis 21.75 13.68 52 25527 43899 63419544
Hypoglycaemia 21.51 13.68 63 25516 60002 63403441
Dizziness 21.49 13.68 266 25313 429659 63033784
Urine albumin/creatinine ratio increased 21.33 13.68 7 25572 302 63463141
Blood pressure systolic increased 21.25 13.68 54 25525 47343 63416100
Metabolic alkalosis 21.25 13.68 14 25565 3047 63460396
Vascular resistance systemic 21.04 13.68 4 25575 15 63463428
Syncope 20.75 13.68 98 25481 117287 63346156
Fatigue 20.64 13.68 244 25335 887784 62575659
Retinal detachment 20.64 13.68 18 25561 5951 63457492
Glycosylated haemoglobin increased 20.26 13.68 25 25554 12373 63451070
Oedema peripheral 20.11 13.68 138 25441 189373 63274070
Anuria 20.02 13.68 25 25554 12526 63450917
Blood creatine phosphokinase increased 19.58 13.68 40 25539 30390 63433053
Lung neoplasm malignant 19.26 13.68 31 25548 19602 63443841
Spinal pain 19.11 13.68 25 25554 13114 63450329
Rash 19.09 13.68 140 25439 560731 62902712
Myalgia 18.81 13.68 112 25467 146417 63317026
Drug intolerance 18.59 13.68 63 25516 308598 63154845
Poor dental condition 18.46 13.68 7 25572 463 63462980
Vomiting 18.41 13.68 322 25257 559295 62904148
Therapeutic product effect decreased 18.34 13.68 31 25548 193156 63270287
Protein urine present 18.29 13.68 17 25562 6103 63457340
Blood creatinine increased 18.28 13.68 77 25502 87767 63375676
Pyelonephritis acute 18.11 13.68 15 25564 4626 63458817
Lower respiratory tract infection 18.08 13.68 16 25563 132291 63331152
Hypovolaemic shock 18.01 13.68 17 25562 6224 63457219
Nephropathy 17.78 13.68 17 25562 6324 63457119
Impaired work ability 17.70 13.68 28 25551 17447 63445996
Iron deficiency 17.70 13.68 18 25561 7212 63456231
Cardiac failure 17.67 13.68 77 25502 89065 63374378
Vulvovaginal inflammation 17.65 13.68 8 25571 831 63462612
Acetonaemia 17.59 13.68 5 25574 132 63463311
Hepatitis D 17.43 13.68 4 25575 43 63463400
Electrocardiogram ST-T segment abnormal 17.34 13.68 6 25573 305 63463138
Hypotonia 17.28 13.68 20 25559 9265 63454178
Weight increased 17.27 13.68 51 25528 260741 63202702
Exostosis 17.25 13.68 28 25551 17834 63445609
Labelled drug-drug interaction medication error 17.21 13.68 24 25555 13375 63450068
Spur cell anaemia 17.19 13.68 4 25575 46 63463397
Drug hypersensitivity 17.00 13.68 66 25513 310621 63152822
Disorientation 16.71 13.68 44 25535 39408 63424035
Serratia infection 16.52 13.68 8 25571 965 63462478
Tinnitus 16.40 13.68 41 25538 35587 63427856
Protrusion tongue 16.32 13.68 6 25573 364 63463079
Stevens-Johnson syndrome 16.29 13.68 33 25546 24917 63438526
Leukocyturia 16.20 13.68 9 25570 1440 63462003
Nail injury 16.17 13.68 7 25572 652 63462791
Inclusion body myositis 16.06 13.68 3 25576 10 63463433
Fear of eating 15.98 13.68 6 25573 386 63463057
Hypocalciuria 15.84 13.68 3 25576 11 63463432
Intracranial haematoma 15.72 13.68 6 25573 404 63463039
Limb discomfort 15.62 13.68 36 25543 29680 63433763
Arrhythmia 15.61 13.68 42 25537 38098 63425345
Urine output decreased 15.56 13.68 21 25558 11349 63452094
Transplant dysfunction 15.47 13.68 14 25565 4858 63458585
Blood glucose decreased 15.24 13.68 29 25550 20923 63442520
Pain 15.13 13.68 209 25370 740419 62723024
Angle closure glaucoma 15.04 13.68 10 25569 2209 63461234
Chronic gastritis 15.04 13.68 11 25568 2830 63460613
Haematoma 14.92 13.68 39 25540 34781 63428662
Blood pressure abnormal 14.91 13.68 24 25555 15174 63448269
Hypersensitivity 14.87 13.68 64 25515 292621 63170822
Gallbladder disorder 14.86 13.68 27 25552 18815 63444628
COVID-19 pneumonia 14.72 13.68 23 25556 14186 63449257
Euglycaemic diabetic ketoacidosis 14.60 13.68 12 25567 3662 63459781
Renal failure 14.51 13.68 89 25490 117563 63345880
Extranodal marginal zone B-cell lymphoma (MALT type) 14.46 13.68 6 25573 503 63462940
Decreased appetite 14.13 13.68 159 25420 250893 63212550
Blood glucose increased 14.12 13.68 69 25510 83687 63379756
Injection site erythema 14.06 13.68 8 25571 83166 63380277
Neglect of personal appearance 14.02 13.68 4 25575 107 63463336
Lymphocytic infiltration 14.01 13.68 7 25572 903 63462540
Red blood cell sedimentation rate abnormal 13.92 13.68 27 25552 19755 63443688
Injection site mass 13.79 13.68 26 25553 18630 63444813
Normocytic anaemia 13.78 13.68 9 25570 1931 63461512
Drug abuse 13.73 13.68 6 25573 72512 63390931

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hyponatraemia 274.54 13.88 267 17158 82424 34857082
Hypokalaemia 223.74 13.88 204 17221 58010 34881496
Acute kidney injury 135.90 13.88 395 17030 304593 34634913
Death 82.95 13.88 48 17377 398001 34541505
Hypomagnesaemia 78.79 13.88 74 17351 21777 34917729
Drug interaction 75.91 13.88 266 17159 225680 34713826
Bradycardia 45.85 13.88 110 17315 75308 34864198
Tachyarrhythmia 45.27 13.88 26 17399 3582 34935924
Hyperkalaemia 43.03 13.88 102 17323 69287 34870219
Atrial fibrillation 41.74 13.88 145 17280 122248 34817258
Obesity 41.48 13.88 41 17384 12837 34926669
Hypoosmolar state 40.31 13.88 10 17415 122 34939384
Drug abuse 38.06 13.88 3 17422 99093 34840413
Postictal paralysis 37.82 13.88 11 17414 253 34939253
Drug ineffective 35.90 13.88 113 17312 456638 34482868
Mucosal dryness 35.60 13.88 16 17409 1315 34938191
Off label use 34.95 13.88 101 17324 419423 34520083
Syncope 34.39 13.88 112 17313 91339 34848167
Left atrial dilatation 32.25 13.88 17 17408 1979 34937527
Lactic acidosis 31.89 13.88 60 17365 34712 34904794
Oedema peripheral 30.98 13.88 130 17295 119682 34819824
Drug dispensed to wrong patient 30.41 13.88 11 17414 513 34938993
Herbal interaction 29.88 13.88 10 17415 369 34939137
Sleep disorder due to a general medical condition 29.73 13.88 23 17402 5198 34934308
Dyspnoea exertional 29.43 13.88 66 17359 43213 34896293
Haematocrit increased 28.59 13.88 16 17409 2097 34937409
Dizziness 28.28 13.88 196 17229 218325 34721181
Varicose vein 26.05 13.88 13 17412 1350 34938156
Endoscopy upper gastrointestinal tract abnormal 25.45 13.88 6 17419 58 34939448
Hypotension 25.34 13.88 193 17232 221456 34718050
Febrile neutropenia 25.00 13.88 19 17406 136830 34802676
Wheezing 24.72 13.88 60 17365 41342 34898164
Myalgia 24.71 13.88 95 17330 84015 34855491
Consciousness fluctuating 24.71 13.88 12 17413 1175 34938331
Pancreatic neoplasm 24.55 13.88 11 17414 897 34938609
Diabetic foot 24.49 13.88 16 17409 2772 34936734
Haemoglobin increased 23.86 13.88 17 17408 3392 34936114
Tumour invasion 23.68 13.88 8 17417 304 34939202
Nail pitting 23.61 13.88 8 17417 307 34939199
Renal artery arteriosclerosis 23.03 13.88 5 17420 32 34939474
Electrolyte imbalance 23.01 13.88 32 17393 14380 34925126
Stenosis 22.26 13.88 12 17413 1461 34938045
Gastrointestinal ischaemia 22.21 13.88 7 17418 213 34939293
Polyuria 21.70 13.88 24 17401 8550 34930956
Rhabdomyolysis 21.69 13.88 79 17346 68084 34871422
Cholestasis 21.67 13.88 44 17381 26904 34912602
Renal artery restenosis 20.88 13.88 4 17421 12 34939494
Onychophagia 19.93 13.88 5 17420 64 34939442
Inappropriate antidiuretic hormone secretion 19.89 13.88 28 17397 12725 34926781
Peripheral artery haematoma 19.52 13.88 5 17420 70 34939436
Angular cheilitis 19.34 13.88 6 17419 173 34939333
Lip swelling 18.96 13.88 31 17394 16049 34923457
Urinary retention 18.96 13.88 50 17375 36238 34903268
Bundle branch block right 18.95 13.88 21 17404 7495 34932011
Hypoparathyroidism 18.53 13.88 8 17417 597 34938909
Ventricular flutter 18.51 13.88 5 17420 87 34939419
Glycosylated haemoglobin decreased 18.33 13.88 7 17418 380 34939126
Renal pain 18.29 13.88 14 17411 3114 34936392
Angioedema 18.02 13.88 50 17375 37324 34902182
Type 2 diabetes mellitus 17.69 13.88 30 17395 16002 34923504
Presyncope 17.61 13.88 33 17392 19026 34920480
Hepatic ischaemia 17.57 13.88 7 17418 426 34939080
Arrhythmia 17.36 13.88 48 17377 35760 34903746
Pneumonia 17.29 13.88 108 17317 362519 34576987
Skin disorder 17.17 13.88 27 17398 13528 34925978
Neutrophilia 16.83 13.88 15 17410 4122 34935384
Oedema genital 16.33 13.88 7 17418 513 34938993
Arterial stenosis 16.24 13.88 9 17416 1157 34938349
Gingival hypoplasia 16.21 13.88 3 17422 7 34939499
Atrioventricular block 16.12 13.88 20 17405 8043 34931463
Electrocardiogram T wave abnormal 16.08 13.88 10 17415 1591 34937915
Toxicity to various agents 16.06 13.88 49 17376 200313 34739193
Crepitations 15.89 13.88 13 17412 3183 34936323
Hypovolaemia 15.49 13.88 21 17404 9213 34930293
Tubulointerstitial nephritis 15.35 13.88 33 17392 20991 34918515
External ear pain 14.99 13.88 3 17422 12 34939494
Renal mass 14.99 13.88 10 17415 1794 34937712
Thrombocytosis 14.95 13.88 14 17411 4098 34935408
Choroidal effusion 14.85 13.88 5 17420 188 34939318
Metastases to peritoneum 14.79 13.88 10 17415 1834 34937672
Malaise 14.07 13.88 148 17277 185677 34753829

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hyponatraemia 1375.05 11.94 943 39244 176905 79527296
Hypokalaemia 690.75 11.94 575 39612 143465 79560736
Acute kidney injury 330.20 11.94 774 39413 518630 79185571
Hypomagnesaemia 193.25 11.94 172 40015 46739 79657462
Drug interaction 172.19 11.94 529 39658 414654 79289547
Inappropriate antidiuretic hormone secretion 157.73 11.94 120 40067 26193 79678008
Death 106.83 11.94 78 40109 566436 79137765
Hypochloraemia 106.32 11.94 42 40145 2473 79701728
Completed suicide 106.30 11.94 4 40183 245763 79458438
Confusional state 104.64 11.94 375 39812 317622 79386579
Atrial fibrillation 98.01 11.94 269 39918 197617 79506584
Off label use 89.37 11.94 204 39983 907011 78797190
Burning mouth syndrome 78.79 11.94 23 40164 530 79703671
Hyponatraemic seizure 78.71 11.94 23 40164 532 79703669
Bradycardia 70.81 11.94 188 39999 135369 79568832
Drug ineffective 68.35 11.94 297 39890 1080616 78623585
Torsade de pointes 68.20 11.94 65 40122 19247 79684954
Rectal polyp 60.53 11.94 25 40162 1652 79702549
Blood pressure increased 59.28 11.94 237 39950 211123 79493078
Drug abuse 57.83 11.94 7 40180 162684 79541517
Labile hypertension 57.44 11.94 18 40169 531 79703670
Maternal exposure during pregnancy 56.46 11.94 3 40184 136535 79567666
Lactic acidosis 53.51 11.94 113 40074 70246 79633955
Electrocardiogram QT prolonged 51.97 11.94 130 40057 90256 79613945
Change of bowel habit 48.65 11.94 25 40162 2732 79701469
Syncope 48.53 11.94 199 39988 179250 79524951
Febrile neutropenia 45.83 11.94 30 40157 230969 79473232
Blood sodium decreased 45.44 11.94 69 40118 33186 79671015
Treatment failure 44.80 11.94 15 40172 170471 79533730
Dizziness 43.30 11.94 430 39757 526011 79178190
Infusion related reaction 42.90 11.94 32 40155 230205 79473996
Oedema peripheral 41.72 11.94 243 39944 252045 79452156
Sensitisation 41.66 11.94 24 40163 3287 79700914
Hypotension 41.35 11.94 370 39817 439947 79264254
Myalgia 41.17 11.94 194 39993 185447 79518754
Pericarditis 40.97 11.94 3 40184 104233 79599968
Infection 40.81 11.94 37 40150 241675 79462526
Left ventricular hypertrophy 40.15 11.94 38 40149 11153 79693048
Presyncope 39.77 11.94 73 40114 40981 79663220
Hyperkalaemia 39.31 11.94 137 40050 114261 79589940
Needle issue 38.76 11.94 40 40147 13028 79691173
Renin increased 38.56 11.94 11 40176 233 79703968
Central nervous system lupus 38.44 11.94 13 40174 490 79703711
Toxicity to various agents 38.01 11.94 99 40088 421441 79282760
Product packaging confusion 37.99 11.94 11 40176 246 79703955
Vessel puncture site haemorrhage 35.88 11.94 10 40177 194 79704007
Angioedema 35.26 11.94 101 40086 75934 79628267
Dyslipidaemia 35.21 11.94 36 40151 11597 79692604
Rhabdomyolysis 35.00 11.94 123 40064 103008 79601193
Product dose omission issue 34.98 11.94 44 40143 247493 79456708
Metabolic acidosis 34.81 11.94 106 40081 82423 79621778
Hypoosmolar state 34.73 11.94 11 40176 336 79703865
Exposure during pregnancy 34.38 11.94 5 40182 101127 79603074
Urine odour abnormal 34.08 11.94 27 40160 6246 79697955
Nasal mucosal disorder 33.75 11.94 11 40176 369 79703832
Postictal paralysis 33.75 11.94 11 40176 369 79703832
Pemphigus 33.68 11.94 5 40182 99577 79604624
Orthostatic hypotension 33.57 11.94 82 40105 56082 79648119
Intestinal haemorrhage 33.51 11.94 27 40160 6399 79697802
Blood pressure inadequately controlled 32.31 11.94 26 40161 6151 79698050
Proctalgia 32.20 11.94 32 40155 9969 79694232
Jaundice 32.00 11.94 78 40109 53271 79650930
Hypertensive angiopathy 31.98 11.94 8 40179 100 79704101
Injection site discomfort 31.92 11.94 24 40163 5142 79699059
Furuncle 31.69 11.94 28 40159 7526 79696675
Tachyarrhythmia 31.61 11.94 27 40160 6935 79697266
Fall 31.61 11.94 380 39807 487249 79216952
Sinusitis 30.59 11.94 32 40155 195469 79508732
Renal artery stenosis 30.43 11.94 20 40167 3462 79700739
Swelling 30.11 11.94 39 40148 216672 79487529
Sprue-like enteropathy 29.34 11.94 14 40173 1304 79702897
Malaise 28.01 11.94 373 39814 489496 79214705
Contraindicated product administered 27.94 11.94 23 40164 157515 79546686
Frustration tolerance decreased 27.92 11.94 26 40161 7476 79696725
Urine abnormality 27.77 11.94 27 40160 8192 79696009
Dehydration 27.75 11.94 217 39970 247970 79456231
Drug dispensed to wrong patient 27.10 11.94 11 40176 695 79703506
Arrhythmia 27.07 11.94 80 40107 61192 79643009
Diabetes mellitus 27.03 11.94 94 40093 78296 79625905
Herbal interaction 26.83 11.94 10 40177 502 79703699
Arthropathy 26.59 11.94 30 40157 177081 79527120
Croup infectious 26.37 11.94 11 40176 745 79703456
Angular cheilitis 26.29 11.94 11 40176 751 79703450
Alopecia 26.05 11.94 48 40139 231307 79472894
Hypovolaemia 26.02 11.94 38 40149 17653 79686548
Metabolic alkalosis 25.85 11.94 20 40167 4469 79699732
Hypoglycaemia 25.37 11.94 110 40077 101484 79602717
Mucosal dryness 25.31 11.94 18 40169 3541 79700660
Bladder disorder 25.30 11.94 27 40160 9138 79695063
Electrolyte imbalance 25.11 11.94 51 40136 30830 79673371
Diabetic foot 24.98 11.94 18 40169 3614 79700587
Glycosylated haemoglobin increased 24.96 11.94 39 40148 19221 79684980
Cholestasis 24.92 11.94 70 40117 52039 79652162
Dysuria 24.91 11.94 69 40118 50882 79653319
Left atrial dilatation 24.88 11.94 17 40170 3136 79701065
Endoscopy upper gastrointestinal tract abnormal 24.69 11.94 6 40181 66 79704135
Polyp 24.38 11.94 25 40162 8082 79696119
Stomatitis 24.13 11.94 23 40164 146734 79557467
Diabetic metabolic decompensation 24.04 11.94 17 40170 3315 79700886
Pain 23.96 11.94 233 39954 703569 79000632
Ischaemic stroke 23.79 11.94 52 40135 33079 79671122
Butterfly rash 23.24 11.94 13 40174 1683 79702518
Glomerular filtration rate decreased 22.78 11.94 41 40146 22661 79681540
Drug hypersensitivity 22.71 11.94 76 40111 298840 79405361
Discomfort 22.69 11.94 18 40169 125599 79578602
Blood pressure abnormal 22.57 11.94 35 40152 17134 79687067
Circulatory collapse 22.51 11.94 55 40132 37613 79666588
Product use in unapproved indication 22.38 11.94 59 40128 250300 79453901
Postoperative wound infection 22.28 11.94 30 40157 12931 79691270
Mass 22.12 11.94 35 40152 17437 79686764
Hyperlactacidaemia 22.01 11.94 20 40167 5575 79698626
Atrioventricular block 21.88 11.94 31 40156 14010 79690191
Hypocalcaemia 21.88 11.94 65 40122 49859 79654342
Osmotic demyelination syndrome 21.84 11.94 12 40175 1501 79702700
Tumour invasion 21.65 11.94 8 40179 392 79703809
Platelet count decreased 21.37 11.94 41 40146 194623 79509578
Nail pitting 21.35 11.94 8 40179 408 79703793
Mental status changes 21.23 11.94 4 40183 66955 79637246
Nocturia 21.02 11.94 30 40157 13651 79690550
Blood creatinine increased 21.01 11.94 142 40045 154915 79549286
Disease progression 20.97 11.94 38 40149 184324 79519877
Renal failure 20.97 11.94 173 40014 200795 79503406
Blood urea increased 20.88 11.94 63 40124 48727 79655474
Impaired healing 20.87 11.94 9 40178 87646 79616555
Renal artery restenosis 20.84 11.94 4 40183 12 79704189
Migraine 20.81 11.94 9 40178 87484 79616717
Lip swelling 20.59 11.94 56 40131 40855 79663346
Helicobacter test positive 20.39 11.94 11 40176 1327 79702874
Fatigue 20.37 11.94 338 39849 929389 78774812
Therapeutic product effect decreased 20.27 11.94 32 40155 163831 79540370
Pneumonia 20.24 11.94 224 39963 660022 79044179
Rheumatoid factor positive 20.24 11.94 3 40184 59836 79644365
Vascular resistance systemic 20.15 11.94 4 40183 15 79704186
Gastrointestinal ischaemia 19.96 11.94 8 40179 489 79703712
Tubulointerstitial nephritis 19.91 11.94 53 40134 38182 79666019
Gravitational oedema 19.66 11.94 12 40175 1827 79702374
Pancreatic neoplasm 19.38 11.94 11 40176 1465 79702736
Renal impairment 19.33 11.94 141 40046 157642 79546559
Blood electrolytes abnormal 19.10 11.94 12 40175 1922 79702279
Haematocrit increased 19.05 11.94 16 40171 4018 79700183
Stenosis 18.98 11.94 13 40174 2409 79701792
Thyroid disorder 18.93 11.94 29 40158 14050 79690151
Chronic gastritis 18.93 11.94 16 40171 4052 79700149
Consciousness fluctuating 18.91 11.94 12 40175 1957 79702244
Eosinophilia 18.89 11.94 58 40129 45287 79658914
Bundle branch block left 18.80 11.94 26 40161 11487 79692714
Injection site erythema 18.66 11.94 8 40179 78189 79626012
Lupus nephritis 18.64 11.94 14 40173 2994 79701207
Glomerular filtration rate increased 18.58 11.94 10 40177 1201 79703000
Psychomotor retardation 18.47 11.94 19 40168 6165 79698036
Mucocutaneous haemorrhage 18.39 11.94 6 40181 202 79703999
Injection site reaction 17.96 11.94 3 40184 54782 79649419
Urinary retention 17.89 11.94 66 40121 56564 79647637
Hypersensitivity 17.72 11.94 70 40117 262169 79442032
Urinary incontinence 17.67 11.94 53 40134 40856 79663345
Paramnesia 17.60 11.94 4 40183 32 79704169
Peripheral coldness 17.53 11.94 30 40157 15940 79688261
Hypovolaemic shock 17.52 11.94 26 40161 12250 79691951
Blood glucose decreased 17.51 11.94 40 40147 26194 79678007
Hypouricaemia 17.51 11.94 7 40180 425 79703776
Ventricular flutter 17.43 11.94 5 40182 108 79704093
Rash maculo-papular 17.42 11.94 65 40122 56013 79648188
Swollen tongue 17.32 11.94 54 40133 42516 79661685
Dyspnoea exertional 17.14 11.94 88 40099 86985 79617216
Hepatic enzyme increased 17.11 11.94 42 40145 182568 79521633
Wound 17.08 11.94 20 40167 116159 79588042
Duodenal ulcer perforation 17.08 11.94 6 40181 66205 79637996
Duodenal ulcer 16.99 11.94 30 40157 16339 79687862
Arterial stenosis 16.99 11.94 10 40177 1426 79702775
Therapy non-responder 16.96 11.94 13 40174 92292 79611909
Haemoglobin increased 16.81 11.94 18 40169 6114 79698087
Peripheral artery haematoma 16.70 11.94 5 40182 126 79704075
Disorientation 16.46 11.94 69 40118 62707 79641494
Gingival hypoplasia 16.17 11.94 3 40184 7 79704194
Folliculitis 16.15 11.94 4 40183 55376 79648825
Renal artery arteriosclerosis 16.06 11.94 4 40183 49 79704152
Nephropathy 15.92 11.94 22 40165 9716 79694485
Pyrexia 15.75 11.94 244 39943 678465 79025736
Systemic lupus erythematosus 15.62 11.94 23 40164 121126 79583075
Urine albumin/creatinine ratio increased 15.61 11.94 7 40180 566 79703635
Product use issue 15.49 11.94 54 40133 209768 79494433
Poor dental condition 15.48 11.94 7 40180 577 79703624
Retinal detachment 15.28 11.94 21 40166 9226 79694975
Oedema genital 15.23 11.94 7 40180 599 79703602
Convulsive threshold lowered 15.03 11.94 8 40179 939 79703262
Nail injury 14.99 11.94 7 40180 621 79703580
Glossodynia 14.97 11.94 18 40169 103319 79600882
Lung neoplasm malignant 14.95 11.94 39 40148 27753 79676448
Anaemia megaloblastic 14.92 11.94 7 40180 628 79703573
Bundle branch block right 14.88 11.94 23 40164 11228 79692973
Blood glucose increased 14.80 11.94 104 40083 114871 79589330
Inappropriate schedule of product administration 14.79 11.94 28 40159 133600 79570601
Oliguria 14.55 11.94 28 40159 16281 79687920
Abdominal discomfort 14.47 11.94 71 40116 250656 79453545
Spinal pain 14.44 11.94 27 40160 15365 79688836
Transplant dysfunction 14.42 11.94 18 40169 7203 79696998
Stevens-Johnson syndrome 14.40 11.94 48 40139 39118 79665083
Lower respiratory tract infection 14.37 11.94 27 40160 129193 79575008
Multiple sclerosis relapse 14.29 11.94 3 40184 46530 79657671
Glycosylated haemoglobin decreased 14.25 11.94 7 40180 695 79703506
Ventricular extrasystoles 14.23 11.94 31 40156 19673 79684528
Pain in jaw 14.12 11.94 3 40184 46148 79658053
Wrong technique in product usage process 14.09 11.94 10 40177 73865 79630336
Polydipsia 14.05 11.94 17 40170 6588 79697613
Diabetes mellitus inadequate control 14.04 11.94 35 40152 24229 79679972
Swelling face 14.04 11.94 72 40115 71140 79633061
Drug intolerance 14.00 11.94 77 40110 264042 79440159
Platelet dysfunction 13.98 11.94 6 40181 436 79703765
Varicose vein 13.97 11.94 14 40173 4405 79699796
Proteinuria 13.94 11.94 42 40145 32460 79671741
Hypoparathyroidism 13.92 11.94 8 40179 1090 79703111
Protrusion tongue 13.92 11.94 6 40181 441 79703760
Exostosis 13.90 11.94 28 40159 16830 79687371
Gingival hypertrophy 13.89 11.94 12 40175 3130 79701071
External ear pain 13.81 11.94 3 40184 19 79704182
Musculoskeletal stiffness 13.62 11.94 44 40143 174964 79529237
Fear of eating 13.59 11.94 6 40181 467 79703734
Euglycaemic diabetic ketoacidosis 13.57 11.94 17 40170 6827 79697374
Hepatitis D 13.47 11.94 4 40183 98 79704103
Plasma cell myeloma 13.44 11.94 5 40182 53254 79650947
Hyperlipidaemia 13.41 11.94 36 40151 26057 79678144
Blood pressure systolic increased 13.39 11.94 68 40119 66918 79637283
Pemphigoid 13.30 11.94 26 40161 15289 79688912
Ejection fraction decreased 13.28 11.94 43 40144 34534 79669667
Muscle injury 13.23 11.94 4 40183 48557 79655644
Loss of consciousness 13.17 11.94 136 40051 167807 79536394
Hypocalciuria 13.09 11.94 3 40184 25 79704176
Hospitalisation 13.04 11.94 17 40170 94219 79609982
Product monitoring error 12.91 11.94 19 40168 8887 79695314
Heart rate irregular 12.87 11.94 41 40146 32638 79671563
Glucose tolerance impaired 12.82 11.94 18 40169 8066 79696135
Spur cell anaemia 12.80 11.94 4 40183 117 79704084
Unevaluable event 12.77 11.94 6 40181 55579 79648622
Vulvovaginal inflammation 12.77 11.94 6 40181 540 79703661
Hyperuricaemia 12.73 11.94 22 40165 11777 79692424
Pancytopenia 12.67 11.94 42 40145 165703 79538498
Ephelides 12.64 11.94 4 40183 122 79704079
Rheumatoid arthritis 12.63 11.94 58 40129 208412 79495789
Asthenia 12.53 11.94 342 39845 511347 79192854
Brain stem haematoma 12.48 11.94 4 40183 127 79704074
Polyuria 12.45 11.94 25 40162 14989 79689212
Angle closure glaucoma 12.42 11.94 11 40176 2965 79701236
Extranodal marginal zone B-cell lymphoma (MALT type) 12.27 11.94 6 40181 590 79703611
Fungal infection 12.20 11.94 3 40184 41745 79662456
Osteoporosis 12.19 11.94 6 40181 54106 79650095
Sleep disorder due to a general medical condition 12.11 11.94 24 40163 14253 79689948
Hypertensive crisis 12.06 11.94 30 40157 20740 79683461
Acetonaemia 12.01 11.94 5 40182 337 79703864
Pyelonephritis acute 12.00 11.94 15 40172 6008 79698193

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C03BA11 CARDIOVASCULAR SYSTEM
DIURETICS
LOW-CEILING DIURETICS, EXCL. THIAZIDES
Sulfonamides, plain
ATC C09BX01 CARDIOVASCULAR SYSTEM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, COMBINATIONS
ACE inhibitors, other combinations
ATC C10BX13 CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS
LIPID MODIFYING AGENTS, COMBINATIONS
Lipid modifying agents in combination with other drugs
FDA PE N0000175359 Increased Diuresis
FDA EPC N0000175420 Thiazide-like Diuretic
MeSH PA D000959 Antihypertensive Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D004232 Diuretics
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D045283 Natriuretic Agents
MeSH PA D049993 Sodium Chloride Symporter Inhibitors
CHEBI has role CHEBI:35498 diuretics
CHEBI has role CHEBI:35674 antihypertensive drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypertensive disorder indication 38341003 DOID:10763
Edema indication 267038008
Anuria contraindication 2472002 DOID:2983
Dehydration contraindication 34095006
Hyperuricemia contraindication 35885006 DOID:1920
Hypokalemia contraindication 43339004
Sympathectomy contraindication 57071006
Acute nephropathy contraindication 58574008
Hyperparathyroidism contraindication 66999008 DOID:13543
Diabetes mellitus contraindication 73211009 DOID:9351
Oliguria contraindication 83128009
Hyponatremia contraindication 89627008
Gout contraindication 90560007 DOID:13189
Disease of liver contraindication 235856003 DOID:409




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 8.53 acidic
pKa2 9.54 acidic
pKa3 5.52 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Solute carrier family 12 member 3 Transporter INHIBITOR A2 7.54 WOMBAT-PK CHEMBL
Carbonic anhydrase 1 Enzyme Kd 5 CHEMBL
Carbonic anhydrase 4 Enzyme Ki 6.67 CHEMBL
Carbonic anhydrase 9 Enzyme Ki 7.44 CHEMBL
Carbonic anhydrase 12 Enzyme Ki 8 CHEMBL
Potassium voltage-gated channel subfamily KQT member 1 Ion channel WOMBAT-PK
Carbonic anhydrase 5A, mitochondrial Enzyme Ki 6.05 CHEMBL
Carbonic anhydrase 5B, mitochondrial Enzyme Ki 6.56 CHEMBL
Carbonic anhydrase 7 Enzyme Ki 9.64 CHEMBL
Carbonic anhydrase 6 Enzyme Kd 6.60 CHEMBL
Carbonic anhydrase 14 Enzyme Ki 5.31 CHEMBL
Carbonic anhydrase 2 Enzyme Kd 6.70 CHEMBL
Carbonic anhydrase 13 Enzyme Kd 7 CHEMBL
Arachidonate 15-lipoxygenase Enzyme IC50 5.54 DRUG MATRIX
Carbonic anhydrase 13 Enzyme Ki 7.89 CHEMBL

External reference:

IDSource
4018746 VUID
N0000147050 NUI
D00345 KEGG_DRUG
180004-24-4 SECONDARY_CAS_RN
4018746 VANDF
C0021186 UMLSCUI
CHEBI:5893 CHEBI
BL1 PDB_CHEM_ID
CHEMBL406 ChEMBL_ID
DB00808 DRUGBANK_ID
D007190 MESH_DESCRIPTOR_UI
3702 PUBCHEM_CID
7203 IUPHAR_LIGAND_ID
3333 INN_ID
F089I0511L UNII
5764 RXNORM
2360 MMSL
4873 MMSL
d00260 MMSL
002313 NDDF
387419003 SNOMEDCT_US
725661001 SNOMEDCT_US
74213004 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2571 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2571 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2571 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2597 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2597 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0228-2597 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0378-0069 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 0378-0080 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide Human Prescription Drug Label 1 16571-875 TABLET 1.25 mg ORAL ANDA 18 sections
Indapamide Human Prescription Drug Label 1 16571-876 TABLET 2.50 mg ORAL ANDA 18 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 21695-576 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 42291-348 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 42291-349 TABLET, FILM COATED 2.50 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 51407-024 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 51407-025 TABLET, FILM COATED 2.50 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 62559-510 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 62559-511 TABLET, FILM COATED 2.50 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 63629-1953 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 63629-1953 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 63629-1954 TABLET, FILM COATED 2.50 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 63629-1954 TABLET, FILM COATED 2.50 mg ORAL ANDA 19 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 68151-1294 TABLET, FILM COATED 1.25 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 68788-7247 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 68788-7247 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 68788-7247 TABLET, FILM COATED 2.50 mg ORAL ANDA 20 sections
Indapamide HUMAN PRESCRIPTION DRUG LABEL 1 71335-1541 TABLET, FILM COATED 1.25 mg ORAL ANDA 19 sections